Application of Artificial Intelligence in the Diagnosis, Follow-Up and Prediction of Treatment of Ophthalmic Diseases

Jinwei Yu,Fuqiang Li,Mingzhu Liu,Mengdi Zhang,Xiaoli Liu

DOI: https://doi.org/10.1080/08820538.2024.2414353

2024-10-24

Seminars in Ophthalmology

Abstract:Purpose To describe the application of artificial intelligence (AI) in ophthalmic diseases and its possible future directions.

ophthalmology

What problem does this paper attempt to address?

Applications of Artificial Intelligence in Ophthalmology: General Overview

Wei Lu,Yan Tong,Yue Yu,Yiqiao Xing,Changzheng Chen,Yin Shen

DOI: https://doi.org/10.1155/2018/5278196

2018-11-19

Journal of Ophthalmology

Abstract:With the emergence of unmanned plane, autonomous vehicles, face recognition, and language processing, the artificial intelligence (AI) has remarkably revolutionized our lifestyle. Recent studies indicate that AI has astounding potential to perform much better than human beings in some tasks, especially in the image recognition field. As the amount of image data in imaging center of ophthalmology is increasing dramatically, analyzing and processing these data is in urgent need. AI has been tried to apply to decipher medical data and has made extraordinary progress in intelligent diagnosis. In this paper, we presented the basic workflow for building an AI model and systematically reviewed applications of AI in the diagnosis of eye diseases. Future work should focus on setting up systematic AI platforms to diagnose general eye diseases based on multimodal data in the real world.

ophthalmology
Diagnosing Systemic Disorders with AI Algorithms Based on Ocular Images

Huimin Li,Jing Cao,Andrzej Grzybowski,Kai Jin,Lixia Lou,Juan Ye

DOI: https://doi.org/10.3390/healthcare11121739

2023-01-01

Abstract:The advent of artificial intelligence (AI), especially the state-of-the-art deep learning frameworks, has begun a silent revolution in all medical subfields, including ophthalmology. Due to their specific microvascular and neural structures, the eyes are anatomically associated with the rest of the body. Hence, ocular image-based AI technology may be a useful alternative or additional screening strategy for systemic diseases, especially where resources are scarce. This review summarizes the current applications of AI related to the prediction of systemic diseases from multimodal ocular images, including cardiovascular diseases, dementia, chronic kidney diseases, and anemia. Finally, we also discuss the current predicaments and future directions of these applications.
Artificial Intelligence in Ophthalmic Surgery: Current Applications and Expectations

Maimaiti Nuliqiman,Mingyu Xu,Yiming Sun,Jing Cao,Pengjie Chen,Qi Gao,Peifang Xu,Juan Ye

DOI: https://doi.org/10.2147/OPTH.S438127

2023-01-01

Clinical Ophthalmology

Abstract:Artificial Intelligence (AI) has found rapidly growing applications in ophthalmology, achieving robust recognition and classification in most kind of ocular diseases. Ophthalmic surgery is one of the most delicate microsurgery, requiring high fineness and stability of surgeons. The massive demand of the AI assist ophthalmic surgery will constitute an important factor in boosting accelerate precision medicine. In clinical practice, it is instrumental to update and review the considerable evidence of the current AI technologies utilized in the investigation of ophthalmic surgery involved in both the progression and innovation of precision medicine. Bibliographic databases including PubMed and Google Scholar were searched using keywords such as "ophthalmic surgery", "surgical selection", "candidate screening", and "robot-assisted surgery" to find articles about AI technology published from 2018 to 2023. In addition to the Editorials and letters to the editor, all types of approaches are considered. In this paper, we will provide an up-to-date review of artificial intelligence in eye surgery, with a specific focus on its application to candidate screening, surgery selection, postoperative prediction, and real-time intraoperative guidance.
Artificial intelligence in the anterior segment of eye diseases

Yao-Hong Liu,Lin-Yu Li,Si-Jia Liu,Li-Xiong Gao,Yong Tang,Zhao-Hui Li,Zi Ye

DOI: https://doi.org/10.18240/ijo.2024.09.23

2024-09-18

Abstract:Ophthalmology is a subject that highly depends on imaging examination. Artificial intelligence (AI) technology has great potential in medical imaging analysis, including image diagnosis, classification, grading, guiding treatment and evaluating prognosis. The combination of the two can realize mass screening of grass-roots eye health, making it possible to seek medical treatment in the mode of "first treatment at the grass-roots level, two-way referral, emergency and slow treatment, and linkage between the upper and lower levels". On the basis of summarizing the AI technology carried out by scholars and their teams all over the world in the field of ophthalmology, quite a lot of studies have confirmed that machine learning can assist in diagnosis, grading, providing optimal treatment plans and evaluating prognosis in corneal and conjunctival diseases, ametropia, lens diseases, glaucoma, iris diseases, etc. This paper systematically shows the application and progress of AI technology in common anterior segment ocular diseases, the current limitations, and prospects for the future.
Application of Artificial Intelligence in the Diagnosis and Treatment of Anterior Segment Diseases

Jing-Wen Wang,Wen Xu

DOI: https://doi.org/10.3980/j.issn.1672-5123.2022.5.05

2022-01-01

Abstract:In recent years, the application of artificial intelligence(AI)has been greatly promoted in medical care, especially in the field of image recognition which has played an irreplaceable role in the diagnosis of ophthalmic diseases. AI has made remarkable achievements in the diagnosis and treatment of anterior segment diseases such as classification of infectious keratitis, screening of keratoconus, grading of lens opacity, automatic staging of cataract surgery videos, prediction of postoperative refraction status, and the diagnosis of primary angle-closure glaucoma. It is promising that AI could help solve many clinical problems and realize early diagnosis and treatment of diseases. However, there are still some challenges such as the ambiguity of black-box process, the absence of public data sets and the complexity of algorithms. In this paper, the current studies of AI applications in anterior segment diseases have been reviewed in detail. Also, the challenges and future directions of AI in ophthalmology have been proposed.
An overview of artificial intelligence in diabetic retinopathy and other ocular diseases

Bin Sheng,Xiaosi Chen,Tingyao Li,Tianxing Ma,Yang Yang,Lei Bi,Xinyuan Zhang

DOI: https://doi.org/10.3389/fpubh.2022.971943

IF: 5.2

2022-10-29

Frontiers in Public Health

Abstract:Artificial intelligence (AI), also known as machine intelligence, is a branch of science that empowers machines using human intelligence. AI refers to the technology of rendering human intelligence through computer programs. From healthcare to the precise prevention, diagnosis, and management of diseases, AI is progressing rapidly in various interdisciplinary fields, including ophthalmology. Ophthalmology is at the forefront of AI in medicine because the diagnosis of ocular diseases heavy reliance on imaging. Recently, deep learning-based AI screening and prediction models have been applied to the most common visual impairment and blindness diseases, including glaucoma, cataract, age-related macular degeneration (ARMD), and diabetic retinopathy (DR). The success of AI in medicine is primarily attributed to the development of deep learning algorithms, which are computational models composed of multiple layers of simulated neurons. These models can learn the representations of data at multiple levels of abstraction. The Inception-v3 algorithm and transfer learning concept have been applied in DR and ARMD to reuse fundus image features learned from natural images (non-medical images) to train an AI system with a fraction of the commonly used training data (<1%). The trained AI system achieved performance comparable to that of human experts in classifying ARMD and diabetic macular edema on optical coherence tomography images. In this study, we highlight the fundamental concepts of AI and its application in these four major ocular diseases and further discuss the current challenges, as well as the prospects in ophthalmology.

public, environmental & occupational health
Artificial intelligence in individualized retinal disease management

Zi-Ran Zhang,Jia-Jun Li,Ke-Ran Li

DOI: https://doi.org/10.18240/ijo.2024.08.19

2024-08-18

Abstract:Owing to the rapid development of modern computer technologies, artificial intelligence (AI) has emerged as an essential instrument for intelligent analysis across a range of fields. AI has been proven to be highly effective in ophthalmology, where it is frequently used for identifying, diagnosing, and typing retinal diseases. An increasing number of researchers have begun to comprehensively map patients' retinal diseases using AI, which has made individualized clinical prediction and treatment possible. These include prognostic improvement, risk prediction, progression assessment, and interventional therapies for retinal diseases. Researchers have used a range of input data methods to increase the accuracy and dependability of the results, including the use of tabular, textual, or image-based input data. They also combined the analyses of multiple types of input data. To give ophthalmologists access to precise, individualized, and high-quality treatment strategies that will further optimize treatment outcomes, this review summarizes the latest findings in AI research related to the prediction and guidance of clinical diagnosis and treatment of retinal diseases.
Advances in artificial intelligence applications for ocular surface diseases diagnosis

Yuke Ji,Sha Liu,Xiangqian Hong,Yi Lu,Xingyang Wu,Kunke Li,Keran Li,Yunfang Liu

DOI: https://doi.org/10.3389/fcell.2022.1107689

IF: 5.5

2022-12-21

Frontiers in Cell and Developmental Biology

Abstract:In recent years, with the rapid development of computer technology, continual optimization of various learning algorithms and architectures, and establishment of numerous large databases, artificial intelligence (AI) has been unprecedentedly developed and applied in the field of ophthalmology. In the past, ophthalmological AI research mainly focused on posterior segment diseases, such as diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration, retinal vein occlusion, and glaucoma optic neuropathy. Meanwhile, an increasing number of studies have employed AI to diagnose ocular surface diseases. In this review, we summarize the research progress of AI in the diagnosis of several ocular surface diseases, namely keratitis, keratoconus, dry eye, and pterygium. We discuss the limitations and challenges of AI in the diagnosis of ocular surface diseases, as well as prospects for the future.

cell biology,developmental biology
Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review

Hesam Hashemian,Tunde Peto,Renato Ambrósio Jr,Imre Lengyel,Rahele Kafieh,Ahmed Muhammed Noori,Masoud Khorrami-Nejad

DOI: https://doi.org/10.18502/jovr.v19i3.15893

2024-09-16

Abstract:Artificial intelligence (AI) holds immense promise for transforming ophthalmic care through automated screening, precision diagnostics, and optimized treatment planning. This paper reviews recent advances and challenges in applying AI techniques such as machine learning and deep learning to major eye diseases. In diabetic retinopathy, AI algorithms analyze retinal images to accurately identify lesions, which helps clinicians in ophthalmology practice. Systems like IDx-DR (IDx Technologies Inc, USA) are FDA-approved for autonomous detection of referable diabetic retinopathy. For glaucoma, deep learning models assess optic nerve head morphology in fundus photographs to detect damage. In age-related macular degeneration, AI can quantify drusen and diagnose disease severity from both color fundus and optical coherence tomography images. AI has also been used in screening for retinopathy of prematurity, keratoconus, and dry eye disease. Beyond screening, AI can aid treatment decisions by forecasting disease progression and anti-VEGF response. However, potential limitations such as the quality and diversity of training data, lack of rigorous clinical validation, and challenges in regulatory approval and clinician trust must be addressed for the widespread adoption of AI. Two other significant hurdles include the integration of AI into existing clinical workflows and ensuring transparency in AI decision-making processes. With continued research to address these limitations, AI promises to enable earlier diagnosis, optimized resource allocation, personalized treatment, and improved patient outcomes. Besides, synergistic human-AI systems could set a new standard for evidence-based, precise ophthalmic care.
Artificial intelligence-assisted diagnosis of ocular surface diseases

Zuhui Zhang,Ying Wang,Hongzhen Zhang,Arzigul Samusak,Huimin Rao,Chun Xiao,Muhetaer Abula,Qixin Cao,Qi Dai

DOI: https://doi.org/10.3389/fcell.2023.1133680

IF: 5.5

2023-02-18

Frontiers in Cell and Developmental Biology

Abstract:With the rapid development of computer technology, the application of artificial intelligence (AI) in ophthalmology research has gained prominence in modern medicine. Artificial intelligence-related research in ophthalmology previously focused on the screening and diagnosis of fundus diseases, particularly diabetic retinopathy, age-related macular degeneration, and glaucoma. Since fundus images are relatively fixed, their standards are easy to unify. Artificial intelligence research related to ocular surface diseases has also increased. The main issue with research on ocular surface diseases is that the images involved are complex, with many modalities. Therefore, this review aims to summarize current artificial intelligence research and technologies used to diagnose ocular surface diseases such as pterygium, keratoconus, infectious keratitis, and dry eye to identify mature artificial intelligence models that are suitable for research of ocular surface diseases and potential algorithms that may be used in the future.

cell biology,developmental biology
Systematic Bibliometric and Visualized Analysis of Research Hotspots and Trends on the Application of Artificial Intelligence in Ophthalmic Disease Diagnosis

Junqiang Zhao,Yi Lu,Shaojun Zhu,Keran Li,Qin Jiang,Weihua Yang

DOI: https://doi.org/10.3389/fphar.2022.930520

IF: 5.6

2022-06-08

Frontiers in Pharmacology

Abstract:Background: Artificial intelligence (AI) has been used in the research of ophthalmic disease diagnosis, and it may have an impact on medical and ophthalmic practice in the future. This study explores the general application and research frontier of artificial intelligence in ophthalmic disease detection. Methods: Citation data were downloaded from the Web of Science Core Collection database to evaluate the extent of the application of Artificial intelligence in ophthalmic disease diagnosis in publications from 1 January 2012, to 31 December 2021. This information was analyzed using CiteSpace.5.8. R3 and Vosviewer. Results: A total of 1,498 publications from 95 areas were examined, of which the United States was determined to be the most influential country in this research field. The largest cluster labeled “Brownian motion” was used prior to the application of AI for ophthalmic diagnosis from 2007 to 2017, and was an active topic during this period. The burst keywords in the period from 2020 to 2021 were system, disease, and model. Conclusion: The focus of artificial intelligence research in ophthalmic disease diagnosis has transitioned from the development of AI algorithms and the analysis of abnormal eye physiological structure to the investigation of more mature ophthalmic disease diagnosis systems. However, there is a need for further studies in ophthalmology and computer engineering.

pharmacology & pharmacy
Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives

Kai Jin,Juan Ye

DOI: https://doi.org/10.1016/j.aopr.2022.100078

2022-11-01

Advances in Ophthalmology Practice and Research

Abstract:BackgroundThe ophthalmology field was among the first to adopt artificial intelligence (AI) in medicine. The availability of digitized ocular images and substantial data have made deep learning (DL) a popular topic.Main textAt the moment, AI in ophthalmology is mostly used to improve disease diagnosis and assist decision-making aiming at ophthalmic diseases like diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), cataract and other anterior segment diseases. However, most of the AI systems developed to date are still in the experimental stages, with only a few having achieved clinical applications. There are a number of reasons for this phenomenon, including security, privacy, poor pervasiveness, trust and explainability concerns.ConclusionsThis review summarizes AI applications in ophthalmology, highlighting significant clinical considerations for adopting AI techniques and discussing the potential challenges and future directions.
Artificial Intelligence for Anterior Segment Diseases: A Review of Potential Developments and Clinical Applications

Zhe Xu,Jia Xu,Ce Shi,Wen Xu,Xiuming Jin,Wei Han,Kai Jin,Andrzej Grzybowski,Ke Yao

DOI: https://doi.org/10.1007/s40123-023-00690-4

2023-01-01

Ophthalmology and Therapy

Abstract:Artificial intelligence (AI) technology is promising in the field of healthcare. With the developments of big data and image-based analysis, AI shows potential value in ophthalmology applications. Recently, machine learning and deep learning algorithms have made significant progress. Emerging evidence has demonstrated the capability of AI in the diagnosis and management of anterior segment diseases. In this review, we provide an overview of AI applications and potential future applications in anterior segment diseases, focusing on cornea, refractive surgery, cataract, anterior chamber angle detection, and refractive error prediction.
Applications of Artificial Intelligence in Myopia: Current and Future Directions

Chenchen Zhang,Jing Zhao,Zhe Zhu,Yanxia Li,Ke Li,Yuanping Wang,Yajuan Zheng

DOI: https://doi.org/10.3389/fmed.2022.840498

2022-03-11

Abstract:With the continuous development of computer technology, big data acquisition and imaging methods, the application of artificial intelligence (AI) in medical fields is expanding. The use of machine learning and deep learning in the diagnosis and treatment of ophthalmic diseases is becoming more widespread. As one of the main causes of visual impairment, myopia has a high global prevalence. Early screening or diagnosis of myopia, combined with other effective therapeutic interventions, is very important to maintain a patient's visual function and quality of life. Through the training of fundus photography, optical coherence tomography, and slit lamp images and through platforms provided by telemedicine, AI shows great application potential in the detection, diagnosis, progression prediction and treatment of myopia. In addition, AI models and wearable devices based on other forms of data also perform well in the behavioral intervention of myopia patients. Admittedly, there are still some challenges in the practical application of AI in myopia, such as the standardization of datasets; acceptance attitudes of users; and ethical, legal and regulatory issues. This paper reviews the clinical application status, potential challenges and future directions of AI in myopia and proposes that the establishment of an AI-integrated telemedicine platform will be a new direction for myopia management in the post-COVID-19 period.
Prognostic potentials of AI in ophthalmology: systemic disease forecasting via retinal imaging

Yong Yu Tan,Hyun Goo Kang,Chan Joo Lee,Sung Soo Kim,Sungha Park,Sahil Thakur,Zhi Da Soh,Yunnie Cho,Qingsheng Peng,Yih-Chung Tham,Tyler Hyungtaek Rim,Ching-yu Cheng

DOI: https://doi.org/10.1186/s40662-024-00384-3

2024-05-07

Eye and Vision

Abstract:Artificial intelligence (AI) that utilizes deep learning (DL) has potential for systemic disease prediction using retinal imaging. The retina's unique features enable non-invasive visualization of the central nervous system and microvascular circulation, aiding early detection and personalized treatment plans for personalized care. This review explores the value of retinal assessment, AI-based retinal biomarkers, and the importance of longitudinal prediction models in personalized care.

ophthalmology
Application of artificial intelligence in oculoplastics: a review

Yilu Cai,Xuan Zhang,Jing Cao,Andrzej Grzybowski,Juan Ye,Lixia Lou

DOI: https://doi.org/10.1016/j.clindermatol.2023.12.019

IF: 2.797

2024-01-05

Clinics in Dermatology

Abstract:Oculoplastics is a sub-specialty of ophthalmology/dermatology concerned with eyelid, orbital and lacrimal diseases. Artificial intelligence (AI), with its powerful ability to analyze large data sets, has dramatically benefited oculoplastics. The cutting-edge AI technology is widely applied to extract ocular parameters and to use these results for further assessment, such as screening and diagnosis of blepharoptosis and predicting the progression of thyroid eye disease. AI also assists in treatment procedures, such as surgical strategy planning in blepharoptosis. High efficiency and high reliability prove to be the most apparent advantages of AI, with promising prospects. The prospects of AI in oculoplastics may lie in 3D modeling technology and image generation. We retrospectively summarize A.I. applications involving eyelid, orbital, and lacrimal diseases in oculoplastics., and we also examine the strengths and weaknesses of A.I. technology in oculoplastics.

dermatology
Artificial Intelligence in Predicting Systemic Parameters and Diseases From Ophthalmic Imaging

Bjorn Kaijun Betzler,Tyler Hyungtaek Rim,Charumathi Sabanayagam,Ching-Yu Cheng

DOI: https://doi.org/10.3389/fdgth.2022.889445

2022-05-26

Frontiers in Digital Health

Abstract:Artificial Intelligence (AI) analytics has been used to predict, classify, and aid clinical management of multiple eye diseases. Its robust performances have prompted researchers to expand the use of AI into predicting systemic, non-ocular diseases and parameters based on ocular images. Herein, we discuss the reasons why the eye is well-suited for systemic applications, and review the applications of deep learning on ophthalmic images in the prediction of demographic parameters, body composition factors, and diseases of the cardiovascular, hematological, neurodegenerative, metabolic, renal, and hepatobiliary systems. Three main imaging modalities are included—retinal fundus photographs, optical coherence tomographs and external ophthalmic images. We examine the range of systemic factors studied from ophthalmic imaging in current literature and discuss areas of future research, while acknowledging current limitations of AI systems based on ophthalmic images.
The application of Artificial Intelligence to Ophthalmology: A bibliometric study (2000-2021)

Han Wang,Xiaoshu Zhou,Wencai Du,Lina Huang

DOI: https://doi.org/10.20944/preprints202111.0080.v1

2021-11-03

Abstract:Background. Artificial Intelligence (AI) is an advanced technology for the latest 20 years. Machine learning (ML) and deep learning (DL) are the major innovations for AI, which has been applied for multiple fields. Ophthalmology has become to be one of the most significant disciplines for human healthcare. Methodology. This study utilizes methods of text mining and bibliometric analysis to explore applications of AI to ophthalmology. 179 related articles from Web of Science (WOS) and 96 papers from China National Knowledge Infrastructure (CNKI) are explored during the period of 2000 to 2021. A descriptive analysis of major trends, journal releasing, topic mapping and quotation relationships is implemented in this paper. Leading authors, journals, institutions, nations and references in the related research are identified. Results. Findings show that the application of AI technologies in ophthalmologic diagnosis with optical coherence tomography (OCT) fundus images is the core topic for this area’s studies, especially for diabetic retinopathy (DR), aged macular degeneration (AMD) and glaucoma. It is also be predicted as the core direction over the recent years. Besides, The USA, England and China is the most competitive countries in this scientific filed. Journals of Ophthalmology, Investigative Ophthalmology and Visual Science, Eye, Acta Ophthalmologica and Scientific Reports are the top five journal related to the research area. There is a significant difference between WOS and CNKI databases pertaining to the application of Artificial Intelligence (AI) to ophthalmology, especially for the historic development, topic mapping and discipline category. Finally, the potential academic value of interdisciplinary subject of “AI in Ophthalmology” and tradition Chinese medicine (TRM) is discussed. Limitations and suggestions for the future research is indicated at the end of this paper.
The future application of artificial intelligence and telemedicine in the retina: A perspective

Chu-Ting Wu,Ting-Yi Lin,Cheng-Jun Lin,De-Kuang Hwang

DOI: https://doi.org/10.4103/tjo.tjo-d-23-00028

2023-01-01

Taiwan Journal of Ophthalmology

Abstract:The development of artificial intelligence (AI) and deep learning provided precise image recognition and classification in the medical field. Ophthalmology is an exceptional department to translate AI applications since noninvasive imaging is routinely used for the diagnosis and monitoring. In recent years, AI-based image interpretation of optical coherence tomography and fundus photograph in retinal diseases has been extended to diabetic retinopathy, age-related macular degeneration, and retinopathy of prematurity. The rapid development of portable ocular monitoring devices coupled with AI-informed interpretations allows possible home monitoring or remote monitoring of retinal diseases and patients to gain autonomy and responsibility for their conditions. This review discusses the current research and application of AI, telemedicine, and home monitoring devices on retinal disease. Furthermore, we propose a future model of how AI and digital technology could be implemented in retinal diseases.

English Else
Artificial intelligence for retinal diseases

Jennifer I Lim,Aleksandra V Rachitskaya,Joelle A Hallak,Sina Gholami,Minhaj N Alam

DOI: https://doi.org/10.1016/j.apjo.2024.100096

Abstract:Purpose: To discuss the worldwide applications and potential impact of artificial intelligence (AI) for the diagnosis, management and analysis of treatment outcomes of common retinal diseases. Methods: We performed an online literature review, using PubMed Central (PMC), of AI applications to evaluate and manage retinal diseases. Search terms included AI for screening, diagnosis, monitoring, management, and treatment outcomes for age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal surgery, retinal vascular disease, retinopathy of prematurity (ROP) and sickle cell retinopathy (SCR). Additional search terms included AI and color fundus photographs, optical coherence tomography (OCT), and OCT angiography (OCTA). We included original research articles and review articles. Results: Research studies have investigated and shown the utility of AI for screening for diseases such as DR, AMD, ROP, and SCR. Research studies using validated and labeled datasets confirmed AI algorithms could predict disease progression and response to treatment. Studies showed AI facilitated rapid and quantitative interpretation of retinal biomarkers seen on OCT and OCTA imaging. Research articles suggest AI may be useful for planning and performing robotic surgery. Studies suggest AI holds the potential to help lessen the impact of socioeconomic disparities on the outcomes of retinal diseases. Conclusions: AI applications for retinal diseases can assist the clinician, not only by disease screening and monitoring for disease recurrence but also in quantitative analysis of treatment outcomes and prediction of treatment response. The public health impact on the prevention of blindness from DR, AMD, and other retinal vascular diseases remains to be determined.

Application of Artificial Intelligence in the Diagnosis, Follow-Up and Prediction of Treatment of Ophthalmic Diseases

Applications of Artificial Intelligence in Ophthalmology: General Overview

Diagnosing Systemic Disorders with AI Algorithms Based on Ocular Images

Artificial Intelligence in Ophthalmic Surgery: Current Applications and Expectations

Artificial intelligence in the anterior segment of eye diseases

Application of Artificial Intelligence in the Diagnosis and Treatment of Anterior Segment Diseases

An overview of artificial intelligence in diabetic retinopathy and other ocular diseases

Artificial intelligence in individualized retinal disease management

Advances in artificial intelligence applications for ocular surface diseases diagnosis

Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review

Artificial intelligence-assisted diagnosis of ocular surface diseases

Systematic Bibliometric and Visualized Analysis of Research Hotspots and Trends on the Application of Artificial Intelligence in Ophthalmic Disease Diagnosis

Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives

Artificial Intelligence for Anterior Segment Diseases: A Review of Potential Developments and Clinical Applications

Applications of Artificial Intelligence in Myopia: Current and Future Directions

Prognostic potentials of AI in ophthalmology: systemic disease forecasting via retinal imaging

Application of artificial intelligence in oculoplastics: a review

Artificial Intelligence in Predicting Systemic Parameters and Diseases From Ophthalmic Imaging

The application of Artificial Intelligence to Ophthalmology: A bibliometric study (2000-2021)

The future application of artificial intelligence and telemedicine in the retina: A perspective

Artificial intelligence for retinal diseases